Applied DNA Sciences Files 2025 Proxy Statement

TL;DR

APDN proxy filed for Jan 23, 2025 meeting. Vote on directors & company matters.

AI Summary

Applied DNA Sciences Inc. is filing its definitive proxy statement for the 2025 annual meeting of stockholders, scheduled for January 23, 2025. The filing, submitted on December 10, 2024, outlines the proposals to be voted on by shareholders, including the election of directors and other corporate matters. The company is incorporated in Delaware and headquartered in Stony Brook, NY.

Why It Matters

This filing provides shareholders with crucial information about the company's governance and the proposals they will vote on, impacting the future direction and leadership of Applied DNA Sciences.

Risk Assessment

Risk Level: low — This is a routine proxy filing and does not contain new financial information or significant corporate events that would immediately impact stock price.

Key Numbers

• 2025 — Annual Meeting Year (The proxy statement is for the company's 2025 annual meeting.)
• January 23 — Meeting Date (Shareholders will vote on proposals at the meeting scheduled for this date.)

Key Players & Entities

• APPLIED DNA SCIENCES INC (company) — Registrant
• 2025 (date) — Annual Meeting Year
• January 23, 2025 (date) — Annual Meeting Date
• December 10, 2024 (date) — Filing Date
• Stony Brook, NY (location) — Company Headquarters

FAQ

Key Financial Figures

• $9,000 — reed to pay Kingsdale Advisors a fee of $9,000 plus reimburse them for certain out- of

Filing Documents

• tm2428454d2_def14a.htm (DEF 14A) — 153KB
• tm2428454d2_def14aimg001.jpg (GRAPHIC) — 4KB
• tm2428454d2_def14aimg003.jpg (GRAPHIC) — 94KB
• tmb-20241205xcorrespg002.jpg (GRAPHIC) — 122KB
• 0001104659-24-127169.txt ( ) — 459KB

BUSINESS

BUSINESS 13 STOCKHOLDER PROPOSALS AND NOMINATIONS 14 ANNUAL REPORT ON FORM 10-K AND OTHER INFORMATION 15 APPLIED DNA SCIENCES, INC. 50 HEALTH SCIENCES DRIVE STONY BROOK, NEW YORK 11790 PROXY STATEMENT The board of directors (the “ Board of Directors ”) of Applied DNA Sciences, Inc. (“ Applied DNA Sciences ” or the “ Company ”) has made this proxy statement and related materials (this “ Proxy Statement ”) available to you on the Internet, or, upon your request, has delivered printed proxy materials to you by mail, in connection with the Board of Directors’ solicitation of proxies for use at a Special Meeting of Stockholders (the “ Special Meeting ”) of Applied DNA Sciences, Inc. to be held online on Thursday, January 23, 2025, beginning at 11:00 a.m., Eastern Time, and at any postponements or adjournments of the Special Meeting. As a stockholder, you are invited to attend the Special Meeting and are requested to vote on the items of business described in this Proxy Statement. ABOUT THE SPECIAL MEETING Why did I receive a notice in the mail regarding the Internet availability of proxy materials instead of a full set of proxy materials? In accordance with rules adopted by the Securities and Exchange Commission (“ SEC ”), we are providing access to our proxy materials over the Internet. Accordingly, we are sending a Notice Regarding Availability of Proxy Materials (the “ Notice ”) to our stockholders of record and beneficial owners as of the record date (as defined below) (for more information on the record date, see “— Who is entitled to vote at the Special Meeting? ”). The mailing of the Notice to our stockholders is scheduled to begin on or about December 10, 2024. All stockholders will have the ability to access the proxy materials and our Annual Report on Form 10-K for the fiscal year ended September 30, 2023 (the “ Annual Report &

View Full Filing

View this DEF 14A filing on SEC EDGAR